Credence Research Logo

Home » Healthcare » Pharmaceuticals » Freezing of Gait Treatment Market

Freezing of Gait Treatment Market By Treatment Type (Oral Dopaminergic Medication, Wearable and Walking Aid Devices, Deep Brain Stimulation), By End User Segment (Hospitals, Clinics, Research and Academic Institutes) – Growth, Future Prospects, and Competitive Analysis, 2019 – 2027

Report ID: 5675 | Report Format : Excel, PDF

Freezing gait treatment market to exhibit productive growth during the forecast period.

The global freezing of gait treatment market is growing at a CAGR of 7.2%. Globally, the increasing prevalence of Parkinson’s disease has significantly increased the revenue of oral dopaminergic medications. In addition, FDA approval for new drugs and promising pipeline products in the equipment and devices segment in the Parkinson’s disease industry is driving the overall growth freezing of the gait treatment market globally. 

Market Synopsis

Oral dopaminergic medication segment is expected to register higher growth by the end of 2027

Levodopa (Inbrija™, by Acorda Therapeutics) and carbidopa remain the optimum standard of symptomatic treatment for (FoG) Parkinson’s disease orally. In Dec 2018, the U.S. FDA approved Inbrija™ for the alternating treatment of “OFF” incidents in people with Parkinson’s disease who are already treated with levodopa/carbidopa. It is a novel approach for the treatment of OFF periods in PD. Advanced pipeline products in the wearable and walking aid segment will show promising growth in the near future. E.g., At the CES 2018 conference in Las Vegas, a Chinese company named GYENNO showcased its gait aid equipment package, which mainly helps to escape gait freeze in Parkinson’s patients. Additionally, Kyungpook National University showcased an android-based gait-aid system using smart glasses with wearable sensors.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research Inc.!

Download Sample

Increasing admissions for freezing of gait in the hospital segment to witness a significant CAGR

Increasing chronic Parkinson’s disease (PD), along with significant hospital admissions internationally, are notable factors expected for the market’s growth. According to FDA and other research studies, symptomatic and neuroprotective therapies are opted for PD in hospitals. In addition, deep brain stimulation procedures, along with helpful brain exercises, are also adopted in the end-user segment, showed promising results in recent times. Moreover, the increasing elderly population and admissions are escalating the growth in the end-user segment. Moreover, the lunch of new medications and equipment in the U.S. market and internationally, along with increased funding for PD patient care for the administration of freezing of gait treatment on a global scale, will drive the growth during the forecast period.

Increasing population, new FDA approval, and the presence of top players hold the U.S. in a dominant position

In 2018, the U.S contributed the maximum revenue share in the freezing of the gait treatment market due to the rising prevalence of PD. Key prime factors include rising awareness about new medications and therapies, FDA approvals for new drugs, and rising PD care services along with enhanced reimbursement structure will drive the demand in the near future. In addition, emerging nations always suffer the burden of chronic diseases. Nevertheless, there is no significant treatment targeted towards freezing of gait in PD, but strong pipeline drugs and products, along with the approval for levodopa, will further enhance the growth on a global scale. 

Increased research and development with strong product pipelines in the developed regions

Major players in the freezing of gait treatment market are Acorda Therapeutics, The Michael J. Fox Foundation, GYENNO, National University of Ireland, Galway (NUI Galway), Kyungpook National University, Republic of Korea, MedEXO Robotics, TABLE Teva Pharmaceuticals, and others. In addition, major organizations and research centers are developing progressive technologies with new technology expansion in the wearable and walking aids systems, electronic brain implants, and other stimulators for freezing gait treatment on a global scale.

Historical & Forecast Period

This study report represents an analysis of each segment from 2017 to 2027, considering 2018 to be the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period from 2019 to 2027.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Segmentation Treatment Type (2017–2027; US$ Mn)

  •  Oral Dopaminergic Medication (Inbrija – levodopa inhalation powder)
  •  Wearable and Walking Aid Devices
  •  Deep Brain Stimulation
  •  Others (Brain Implants)

End-User Segment (2017–2027; US$ Mn)

  •  Hospitals
  •  Clinics
  •  Research and Academic Institutes

Geography Segment (2017–2027; US$ Mn)

  •  North America (U.S., Canada)
  •  Europe (U.K., Germany, Rest of Europe)
  •  Asia Pacific (Japan, China, Rest of Asia Pacific)
  •  Latin America (Brazil, Mexico, Rest of Latin America)
  •  Middle East & Africa (GCC, Rest of the Middle East & Africa)

The current report also comprehends qualitative and qualitative market valuation factors such as key market drivers, market trends, restraints, and opportunities that give a better market understanding of the overall freezing of the gait treatment market. The global report also comprises a graphical representation of the competitive landscape based on their market initiatives and strategies, product portfolio, and business strengths.

Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I – Secondary Research
1.4.2. Phase II – Primary Research
1.4.3. Phase III – Expert Panel Review
1.4.4. Assumptions
1.5. Market Segmentation

Chapter 2. Executive Summary
2.1. Global FGT Market Portraiture
2.2. Global FGT Market, By Treatment Type, 2018 (US$ Mn)
2.3. Global FGT Market, By End User, 2018 (US$ Mn)
2.4. Global FGT Market, by Geography, 2018 vs. 2027 (Value %)

Chapter 3. Global Freezing of Gait Treatment (FGT) Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. FGT Market Technologies: Future Trends
3.3. Current Scenario: New Product Launches, High Prevalence For Parkinson’s Disease
3.4. Challenges
3.5. Opportunities
3.6. Attractive Investment Proposition, by Geography, 2018
3.7. Competitive Landscape
3.7.1. Competitive Landscape, by Key Players, 2018

Chapter 4. Global Freezing of Gait Treatment (FGT) Market, by Treatment Type, 2017 – 2027 (US$ Mn)
4.1. Overview
4.2. Oral Dopaminergic Medication (Inbrija – levodopa inhalation powder)
4.3. Wearable and Walking Aid Devices
4.4. Deep Brain Stimulation
4.5. Others (Brain Implants)

Chapter 5. Global Freezing of Gait Treatment (FGT) Market, By End User, 2017 – 2027 (US$)
5.1. Overview
5.2. Hospitals
5.3. Clinics
5.4. Research and Academic Institutes

Chapter 6. Global Freezing of Gait Treatment (FGT) Market, by Geography, 2017 – 2027 (US$ Mn)
6.1. Overview
6.2. North America FGT Market Analysis, 2017 – 2027
6.2.1. North America FGT Market, By Treatment Type, 2017 – 2027 (US$ Mn)
6.2.2. North America FGT Market, By End User, 2017 – 2027 (US$ Mn)
6.2.3. North America FGT Market, by Country, 2017 – 2027 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe FGT Market Analysis, 2017 – 2027
6.3.1. Europe FGT Market, By Treatment Type, 2017 – 2027 (US$ Mn)
6.3.2. Europe FGT Market, By End User, 2017 – 2027 (US$ Mn)
6.3.3. Europe FGT Market, by Country, 2017 – 2027 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific FGT Market Analysis, 2017 – 2027
6.4.1. Asia Pacific FGT Market, By Treatment Type, 2017 – 2027 (US$ Mn)
6.4.2. Asia Pacific FGT Market, By End User, 2017 – 2027 (US$ Mn)
6.4.3. Asia Pacific FGT Market, by Country, 2017 – 2027 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. Rest of APAC
6.5. Latin America FGT Market Analysis, 2017 – 2027
6.5.1. Latin America FGT Market, By Treatment Type, 2017 – 2027 (US$ Mn)
6.5.2. Latin America FGT Market, By End User, 2017 – 2027 (US$ Mn)
6.5.3. Latin America FGT Market, by Country, 2017 – 2027 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) FGT Market Analysis, 2017 – 2027
6.6.1. MEA FGT Market, by Treatment Type, 2017 – 2027 (US$ Mn)
6.6.2. MEA FGT Market, By End User, 2017 – 2027 (US$ Mn)
6.6.3. MEA FGT Market, by Region, 2017 – 2027 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Acorda Therapeutics
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. The Michael J. Fox Foundation
7.3. GYENNO
7.4. National University of Ireland, Galway (NUI Galway)
7.5. Kyungpook National University, Republic of Korea
7.6. MedEXO Robotics

List of Figures

FIG. 1 Global Freezing of Gait Treatment (FGT) Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global FGT Market Segmentation
FIG. 4 Global FGT Market, by Treatment Type, 2017 (US$ Mn)
FIG. 5 Global FGT Market, by End User, 2017 (US$ Mn)
FIG. 6 Global FGT Market, by Geography, 2017 (US$ Mn)
FIG. 7 Attractive Investment Proposition, by Geography, 2017
FIG. 8 Global Market Positioning of Key FGT Market Manufacturers, 2017
FIG. 9 Global FGT Market for Oral Dopaminergic Medication, 2017–2027 (US$ Mn)
FIG. 10 Global FGT Market for Wearable and Walking Aid Devices, 2017–2027 (US$ Mn)
FIG. 11 Global FGT Market for Deep Brain Stimulation, 2017–2027 (US$ Mn)
FIG. 12 Global FGT Market for Others (Brain Implants), 2017–2027 (US$ Mn)
FIG. 13 Global Hospitals Market (End User), 2017–2027 (US$ Mn)
FIG. 14 Global Clinics Market (End User), 2017–2027 (US$ Mn
FIG. 15 Global Research and Academic Institutes Market (End User), 2017–2027 (US$ Mn
FIG. 16 U.S. FGT Market, 2017–2027 (US$ Mn)
FIG. 17 Canada FGT Market, 2017–2027 (US$ Mn)
FIG. 18 U.K. FGT Market, 2017–2027 (US$ Mn)
FIG. 19 Germany FGT Market, 2017–2027 (US$ Mn)
FIG. 20 Rest of Europe FGT Market, 2017–2027 (US$ Mn)
FIG. 21 Japan FGT Market, 2017–2027 (US$ Mn)
FIG. 22 China FGT Market, 2017–2027 (US$ Mn)
FIG. 23 Rest of Asia Pacific FGT Market, 2017–2027 (US$ Mn)
FIG. 24 Brazil FGT Market, 2017–2027 (US$ Mn)
FIG. 25 Mexico FGT Market, 2017–2027 (US$ Mn)
FIG. 26 Rest of Latin America FGT Market, 2017–2027 (US$ Mn)
FIG. 27 GCC FGT Market, 2017–2027 (US$ Mn)
FIG. 28 Rest of Middle East & Africa FGT Market, 2017–2027 (US$ Mn)

List of Tables

TABLE 1 Market Snapshot: Global Freezing of Gait Treatment (FGT) Market
TABLE 2 Global FGT Market, by Treatment Type, 2017–2027 (US$ Mn)
TABLE 3 Global FGT Market, by End User, 2017–2027 (US$ Mn)
TABLE 4 Global FGT Market, by Geography, 2017–2027 (US$ Mn)
TABLE 5 North America FGT Market, by Treatment Type, 2017–2027 (US$ Mn)
TABLE 6 North America FGT Market, by End User, 2017–2027 (US$ Mn)
TABLE 7 North America FGT Market, by Country, 2017–2027 (US$ Mn)
TABLE 8 Europe FGT Market, by Treatment Type, 2017–2027 (US$ Mn)
TABLE 9 Europe FGT Market, by End User, 2017–2027 (US$ Mn)
TABLE 10 Europe FGT Market, by Country/Region, 2017–2027 (US$ Mn)
TABLE 11 Latin America FGT Market, by Treatment Type, 2017–2027 (US$ Mn)
TABLE 12 Latin America FGT Market, by End User, 2017–2027 (US$ Mn)
TABLE 13 Latin America FGT Market, by Country/Region, 2017–2027 (US$ Mn)
TABLE 14 Asia Pacific FGT Market, by Treatment Type, 2017–2027 (US$ Mn)
TABLE 15 Asia Pacific FGT Market, by End User, 2017–2027 (US$ Mn)
TABLE 16 Asia Pacific FGT Market, by Country/Region, 2017–2027 (US$ Mn)
TABLE 17 Middle East & Africa FGT Market, by Treatment Type, 2017–2027 (US$ Mn)
TABLE 18 Middle East & Africa FGT Market, by End User, 2017–2027 (US$ Mn)
TABLE 19 Middle East & Africa FGT Market, by Region, 2017–2027 (US$ Mn)
TABLE 20 Acorda Therapeutics.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 21 The Michael J. Fox Foundation.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 22 GYENNO..: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 23 National University of Ireland, Galway (NUI Galway): Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 24 Kyungpook National University, Republic of Kore: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 25 MedEXO Robotics: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 26 Teva Pharmaceuticals: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)

Request Sample

Request Free Sample

We prioritize the confidentiality and security of your data. Our promise: your information remains private.

Ready to Transform Data into Decisions?

Request Your Sample Report and Start Your Journey of Informed Choices

Providing the strategic compass for industry titans.

cr-clients-logos

Frequently Asked Questions

What is the size of Freezing of Gait Treatment Market?

The market for Freezing of Gait Treatment Market is expected to reach US$ XX Bn by 2027.

What is the Freezing of Gait Treatment Market CAGR?

The Freezing of Gait Treatment Market is expected to see significant CAGR growth over the coming years, at 7.2%.

What is the Forecast period considered for Freezing of Gait Treatment Market?

The report is forecasted from 2018-2027.

What is the base year considered for Freezing of Gait Treatment Market?

The base year of this report is 2017.

Who are the major players in this market?

Acorda Therapeutics, The Michael J. Fox Foundation, GYENNO, National University of Ireland, Galway (NUI Galway), Kyungpook National University, Republic of Korea, MedEXO Robotics are some of the major players in the global market.

About Author

Shweta Bisht

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Related Reports By Keyword

Individual Quick Freezing Market

The Individual Quick Freezing (IQF) Market is projected to grow from USD 2,450 million in 2024 to an estimated USD 4,100 million by 2032, with a compound annual growth rate (CAGR) of 6.5% from 2025 to 2032.

Cryopreservation Bags and Freezing Bags Market

The Cryopreservation Bags and Freezing Bags market is projected to grow from USD 921 million in 2024 to USD 1,745.9 million by 2032, reflecting a compound annual growth rate (CAGR) of 8.13%.

Individual Quick Freezing (IQF) Fruits Market

The global demand for Individual Quick Freezing (IQF) Fruits was valued at USD 20512.2 Million in 2023 and is expected to reach USD 32370.8 Million in 2032, growing at a CAGR of 5.20% between 2024 and 2032.

Frozen Bakery Products Market

The global Frozen Bakery Products Market is projected to grow from USD 25,434.01 million in 2024 to an estimated USD 40,081.29 million based on 2032, with a compound annual growth rate (CAGR) of 5.85% from 2025 to 2032.

Frozen Tuna Market

The Frozen Tuna Market is projected to grow from USD 4,495 million in 2024 to USD 7,164.34 million by 2032, at a CAGR of 6%.

Frozen Seafood Market

The Frozen seafood market is projected to grow from USD 22,114.21 million in 2024 to USD 33,173.96 million by 2032, with a compound annual growth rate (CAGR) of 5.2%.

Frozen Romaine Market

The Frozen Romaine Market is projected to grow from USD 659.56 million in 2024 to USD 848.57 million by 2032, reflecting a compound annual growth rate (CAGR) of 3.2%.

Frozen Hake Market

The Frozen Hake Market is projected to grow from USD 1,497.2 million in 2024 to USD 2,534.25 million by 2032, with a compound annual growth rate (CAGR) of 6.8%.

Frozen Okra Market

The Frozen Okra Market is projected to grow from USD 793.38 million in 2024 to USD 1094.17 million by 2032, expanding at a compound annual growth rate (CAGR) of 4.1%.

Related Reports

Epilepsy Monitoring Devices Market

Epilepsy Monitoring Device Market size was valued at USD 556.7 million in 2024 and is anticipated to reach USD 822.5 million by 2032, at a CAGR of 5% during the forecast period.

Transthyretin Amyloidosis Treatment Market

The transthyretin amyloidosis treatment market is projected to grow from USD 6,620 million in 2024 to USD 19,070.4 million by 2032, registering a strong CAGR of 14.14% during the forecast period.

Diabetes Diagnostics Market

The diabetes diagnostics market    size was valued at USD 36321 million in 2024 and is anticipated to reach USD 61941.2 million by 2032, at a CAGR of 6.9 % during the forecast period (2024-2032).

Fibrate Drugs Market

Fibrate Drugs Market size stood at USD 3,572.5 million in 2024 and is projected to reach USD 5,355.1 million by 2032, registering a CAGR of 5.19% during the forecast period.

Hypertrophic Cardiomyopathy Treatment Market

Hypertrophic Cardiomyopathy Treatment Market size was valued at USD 2293.4 million in 2024 and is anticipated to reach USD 5061 million by 2032, at a CAGR of 10.4% during the forecast period.

Anti-Obesity Drugs Market

The Anti-Obesity Drugs Market size was valued at USD 3,250.0 million in 2018 to USD 6,980.4 million in 2024 and is anticipated to reach USD 36,326.2 million by 2032, at a CAGR of 23.0% during the forecast period.

India Anti-Obesity Drugs Market

The India Anti-Obesity Drugs Market size was valued at USD 30.1 million in 2018 to USD 239.0 million in 2024 and is anticipated to reach USD 3,451.1 million by 2032, at a CAGR of 39.7% during the forecast period.

Epilepsy Treatment Drugs Market

The Epilepsy Treatment Drugs Market size was valued at USD 11739.4 million in 2024 and is anticipated to reach USD 18291.4 million by 2032, at a CAGR of 5.7% during the forecast period (2024-2032).

Collagen Peptide And Gelatin Market

The Collagen Peptide and Gelatin Market size was valued at USD 1,448.4 million in 2018 to USD 2,417.3 million in 2024 and is anticipated to reach USD 4,738.9 million by 2032, at a CAGR of 8.81% during the forecast period.

Biopharmaceutical Logistics Market

The biopharmaceutical logistics market  size was valued at USD 145692.7 million in 2024 and is anticipated to reach USD 254854.5 million by 2032, at a CAGR of 7.24 % during the forecast period (2024-2032).

Telepharmacy Market

The Telepharmacy market is projected to grow from USD 10,735 million in 2024 to an estimated USD 23,011.4 million by 2032, with a compound annual growth rate (CAGR) of 10% from 2024 to 2032.

Telemedicine Market

The Telemedicine market is projected to grow from USD 141,135 million in 2024 to USD 523,000 million by 2032, registering a robust CAGR of 17.79%.

Purchase Options

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$5999

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
$12999

Let us help you

Credence Staff 3

WILLIAM, North America

+1 304 308 1216

Support Staff at Credence Research

KEITH PHILLIPS, Europe

+44 7809 866 263

Lee - CR Sales Staff

LEE VALLANCE, Asia Pacific

+64 22 017 0275

Kieran Jameson

KIERAN JAMESON, Australia

+61 4192 46279

Report delivery within 24 to 48 hours

What people say?

User Review

Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.

Materials Scientist
(privacy requested)

User Review

The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.

Imre Hof
Management Assistant, Bekaert

Trusted By

cr-clients-logos

Request Sample